These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 15112898)
21. Feasibility and outcome of tandem stem cell autotransplants in multiple myeloma. Galli M; Nicolucci A; Valentini M; Belfiglio M; Delaini F; Crippa C; Barbui AM; Giussani U; Rambaldi A; Barbui T Haematologica; 2005 Dec; 90(12):1643-9. PubMed ID: 16330437 [TBL] [Abstract][Full Text] [Related]
22. [Interferon in the treatment of multiple myeloma]. Kuzmits R; Ludwig H; Cortelezzi A; Van Camp BG; Polli E; Flener R; Scheithauer W Acta Med Austriaca; 1985; 12(5):135-8. PubMed ID: 3914174 [TBL] [Abstract][Full Text] [Related]
23. Effectiveness of two-stage treatment of multiple myeloma with melphalan and with melphalan in combination with cyclophosphamide, carmustine, vincristine and prednisone. Snigurowicz J; Kraj M; Rostkowska J; Maj S; Mariańska B; Mendek E; Roszkowski S; Kilian Z; Kołakowski L Arch Immunol Ther Exp (Warsz); 1981; 29(2):145-53. PubMed ID: 7030265 [No Abstract] [Full Text] [Related]
25. [Treatment of multiple myeloma in stages I and II. Comparative study of an M-2 protocol and melphalan-prednisone]. Montalbán C; Zapatero A; Blanco L; Sevilla F; García Laraña J; Odriozola J Sangre (Barc); 1984; 29(6):993-9. PubMed ID: 6549486 [No Abstract] [Full Text] [Related]
26. Cell kinetics and therapy in multiple myeloma: an update of the M83 protocol. Pileri A; Barbui T; Boccadoro M; Comotti B; Dammacco F; Gallamini A; Marmont F; Neretto G; Petrucci MT; Resegotti L Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():168-9. PubMed ID: 2713554 [No Abstract] [Full Text] [Related]
27. Occurrence of multiple myeloma 13 years after Hodgkin's disease: chance or consequence? Strobel ES; Bauchmüller K; Schmitt-Gräff A; Engelhardt M Ann Hematol; 2005 Nov; 84(12):830-2. PubMed ID: 16132908 [No Abstract] [Full Text] [Related]
29. [Immunoblastic lymphoma as expression of the final phase of IgA multiple myeloma]. Pastor Rubín de Celis E; Ruiz Salmerón RJ; Aguirre Jaca M; Rivas Manga MC; Marín Hernández G Rev Clin Esp; 1992 Oct; 191(5):267-9. PubMed ID: 1475443 [TBL] [Abstract][Full Text] [Related]
30. [Myelomatosis. A study of 138 patients treated with melphalan, prednisone and vincristine with particular attention to the prognostic value of a stage subdivision]. Johnsen HE; Bergmann OJ; Boesen AM; Pedersen BB; Ellegaard J; Bastrup-Madsen P Ugeskr Laeger; 1989 Mar; 151(13):816-21. PubMed ID: 2718264 [TBL] [Abstract][Full Text] [Related]
31. Therapy for multiple myeloma with alternating non-cross-resistant chemotherapy combinations: heterogeneity of tumor responsiveness. Morstyn G; Schechter GP; Ihde DC; Carney DN; Eddy JL; Cohen MH; Minna JD; Bunn PA Cancer Treat Rep; 1984 Dec; 68(12):1439-46. PubMed ID: 6391662 [TBL] [Abstract][Full Text] [Related]
32. [Rheumatoid arthritis and multiple myeloma--the risk of a combination of the 2 diseases]. Lila AM; Mazurov VI; Novik AA Ter Arkh; 1997; 69(2):50-2. PubMed ID: 9173578 [No Abstract] [Full Text] [Related]
33. [High-dose chemotherapy with autologous peripheral blood stem cell transplantation for the treatment of multiple myeloma refractory to conventional chemotherapy]. Shimokawa T; Kajiguchi T; Saito M; Kojima Y; Takeyama H Gan To Kagaku Ryoho; 2003 Feb; 30(2):251-4. PubMed ID: 12610874 [TBL] [Abstract][Full Text] [Related]
34. [Long-term osteoporosis with multiple fractures as the early monosymptomatic stage of multiple myeloma]. Abbrederis K; Gattringer C; König P; Gastl G Onkologie; 1984 Jun; 7(3):152-5. PubMed ID: 6379533 [TBL] [Abstract][Full Text] [Related]
35. High dose chemotherapy followed by autologous haemopoietic stem cell transplant in multiple myeloma. Kumar L; Raju GM; Ganessan K; Shawgi S; Menon H; Wadhwa J; Sharma A; Singh R; Kochupillai V Natl Med J India; 2003; 16(1):16-21. PubMed ID: 12715951 [TBL] [Abstract][Full Text] [Related]